Loading IPO Details...
Upcoming IPOs
Healthcare · Listed on NSE · 21 May 2026 - 25 May 2026
Jagat JoshiBio Medica Laboratories is one of the leading manufacturers of parenteral medicines (injectable products) in India. The firm has been involved in developing a wide range of parenteral medicines targeting both human and animal needs. They manufacture generic medicines in the form of Liquid injections and dry powder injections, which come in various forms of packaging like ampoules and vials.
The company also claims to offer high-quality and safe products, followed by Good Manufacturing Practices (GMP and GLP). Moreover, the company has built a reputation for providing reliable yet effective solutions in the healthcare industry. Its product range includes injectables for the domestic market, Injectables for export, and Injectables for veterinary.
| Date & Time | GMP (₹) | Est. Listing Price | Est. Gain (%) | Est. Profit / Lot (₹) |
|---|---|---|---|---|
| 22-May-2026 12:59 PM | +₹2 | ₹141 | +1.44% | ₹2,000 |
| Category | Subscription (x) | Shares Offered | Shares bid for | Total Amount (₹ Cr) |
|---|---|---|---|---|
| QIB (Ex. Anchor) | 15.94x | 36,000 | 5,74,000 | ₹7.98 Cr |
| NII | 1.30x | 17,55,000 | 22,86,000 | ₹31.78 Cr |
| bNII > ₹10L | 0.86x | 11,70,000 | 10,04,000 | ₹13.96 Cr |
| sNII < ₹10L | 2.19x | 5,85,000 | 12,82,000 | ₹17.82 Cr |
| Retail | 2.92x | 17,92,000 | 52,28,000 | ₹72.67 Cr |
| Market Maker | 1.00x | 1,89,000 | 1,89,000 | ₹2.63 Cr |
| Total | 2.23x | 37,72,000 | 82,77,000 | ₹112.42 Cr |
| Period Ended | 30 NOV 2026 | 31 MAR 2025 | 31 MAR 2024 |
|---|---|---|---|
| Total Income | 28.63 | 38.33 | 15.34 |
| Profit After Tax | 8.66 | 9.79 | 2.50 |
| EBITDA | 13.45 | 15.21 | 5.63 |
| NET Worth | 17.12 | 14.73 | 4.94 |
| Reserves and Surplus | 7.94 | 5.55 | 4.84 |
| Total Borrowing | 38.17 | 15.01 | 10.49 |
| Company Name | EPS (₹) | P/E (x) | NAV (₹) | RoNW (%) | Income (₹ Cr) |
|---|---|---|---|---|---|
| Shukra Pharmaceuticals Limited | 0.22 | 47.57 | 1.43 | 15.90 | 1.43 |
| Zenotech Laboratories Limited | 0.92 | - | 15.76 | 6.01 | 5.61 |
Mukesh Mehta,Pradeep Mehta is the company's promoter of Bio Medica Laboratories .
| Particular | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 96.84% | 67.70% |
| Others* | 3.16% | 32.30% |
Join the discussion
Please sign in to leave a comment or reply.